Comparative Risk of Atrial Fibrillation Onset in Statin‐Treated Patients Initiating Icosapent Ethyl and Omega‐3 Acid Ethyl Esters: A Retrospective Cohort Study
Background Icosapent ethyl (IPE) and omega‐3‐acid ethyl esters (docosahexaenoic acid [DHA]/eicosapentaenoic acid [EPA]) are approved as adjunct therapies to statins for reducing cardiovascular events in at‐risk patients. However, concerns remain regarding a potential link between IPE and atrial fibr...
Saved in:
| Main Authors: | Jyotirmoy Sarker, Michael Kim, Samantha Patton, Przemysław B. Radwański, Mark A. Munger, Kibum Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.038846 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethyl
by: Peter P. Toth, et al.
Published: (2025-03-01) -
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial
by: Rahul Aggarwal, et al.
Published: (2025-03-01) -
Difference of higher fatty acids and their ethyl esters in the distillation and aging of strong-flavor Baijiu
by: WANG Wenlong, XU Defu, AO Zonghua, ZHOU Jun, MING Hongmei, ZHOU Yanni, ZHENG Yilong
Published: (2025-05-01) -
Editorial: Therapeutic strategies to lower residual dyslipidemic CV risk beyond LDL-C and statins
by: Raffaele De Caterina, et al.
Published: (2025-06-01) -
Bioinformatics Analysis of Ester Synthases from Burkholderia anthina and the Molecular Mechanism for Synthesizing Fatty Acid Ethyl Esters
by: Jinghui LAI, et al.
Published: (2025-07-01)